Skip to main content
Trending
Model compressionStrait of hormuzPlanetary defenseSouth korea economyCircuit splitsWatershed restorationAutomotive regulationMultifamily distressEnterprise aiClimate forcingSchool nutritionInformation theoryWi-fi 8 hardwareMarket strategyHvac codeAssessment reformProduction economicsNetwork strategyMetabolic scienceSpace-based sigintManagerial shiftAviation safetyData structuresOffice softwareExercise physiologyZaporizhzhia plantIndex mechanicsReit taxationBiodiversity lossPhotosynthesis limits

Longevity

All HealthNutrition & DietSupplementsMental HealthSleepLongevityMedicineMedications & TreatmentsConditions & DiseasesHormones & EndocrinologySkincareDental HealthFamily HealthChildren's HealthMen's HealthWomen's HealthAging & GeroscienceBiohackingAlternative MedicinePublic HealthMedical ResearchPreventive WellnessHealthy Habits
Research Brief

Landmark $38 Million Trial Launches to Test Rapamycin, Semaglutide, and Dapagliflozin for Healthspan Extension

6 sources · 40d ago

Research Brief

Landmark Study Reveals Male and Female Aging Driven by 'Entirely Distinct' Genetic Programs

7 sources · 43d ago

Research Brief

FDA Greenlights First Human Trial to Reverse Cellular Aging With Yamanaka Factors

6 sources · 44d ago

More in Longevity

Deep DiveNAD+ Precursors

The Evidence Pack: The Clinical Reality of NAD+ Precursors for Human Longevity

Longevity Optimists 40%Evidence-Based Skeptics 40%Regulatory Authorities 20%

6 sources · 55d ago

Research BriefLongevity Medicine

Landmark $38M Trial Tests Rapamycin, GLP-1, and SGLT2 Inhibitors as First Longevity Drugs in Healthy Adults

Geroscience Innovators 45%Clinical Evidence Pragmatists 35%Regulatory & Safety Watchdogs 20%

4 sources · 57d ago

Research BriefSenolytics

The Evidence Pack: How Reprogrammed CAR-T Cells Are Eliminating 'Zombie Cells' to Reverse Aging in Mice

Cellular Biologists 35%Translational Gerontologists 35%Health Economists 30%

5 sources · 63d ago

Deep DiveType 1 Diabetes

First Patient Achieves Sustained Insulin Independence Following Autologous Stem Cell-Derived Islet Transplant

Regenerative Medicine Researchers 40%Clinical Endocrinologists 30%Health Economists 30%

3 sources · 63d ago

Blindspot

Important stories the mainstream barely covered

High-impact news with only 1–3 outlets covering it. These stories matter — they just didn't make the radar.

All blindspots →
health

Supercharged Natural Killer Cells Overcome Solid Tumor Barrier in Major Immunotherapy Advance

Stanford researchers have engineered natural killer immune cells to penetrate and survive inside solid tumors, overcoming a major hurdle in cancer immunotherapy. The breakthrough paves the way for scalable, off-the-shelf cell therapies that do not require patient-specific customization.

Cellular Immunologists 50%Translational Oncologists 30%Healthcare Systems & Patients 20%

Explore more topics

News & PoliticsWorldBusinessFinanceTechnologyArtificial IntelligenceScienceEnergy